Back

The effectiveness of antihypoxic and cardioprotective drug in the rehabilitation of patients with COVID-19 associated pneumonia

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Poster session 1 - COVID-19 and long COVID Cardiovascular Rehabilitation Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Sergei Bondarev

Padova University Hospital, Padua (Italy)

6 More presentations in this session

Presentation thumbnail
Discussants - COVID-19 and long COVID
Presentation thumbnail
Post COVID symptoms of fatigue or dyspnea in young patients are not related to impaired aerobic capacity measured be cardiopulmonary exercise testing
Doctor A. Dritsas (Athens, GR)
Abstract
Presentation thumbnail
Sex-specific differences in exercise-based rehabilitation of patients with Post-COVID-19 Syndrome
Professor B. Schmitz (Ennepetal, DE)
Abstract Slides
Presentation thumbnail
Muscle oxygenation kinetics in Long COVID-19: Illness severity and clinical implications
Doctor C. Luz Goulart (Porto Alegre, BR)
Abstract Slides
Presentation thumbnail
Exploring predictors and correlations of COVID-19 impact in revascularized patients
Doctor O. Musayev (Baku, AZ)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - COVID-19 and long COVID

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024
You may be interested in
thumbnail
Congress Session
How to prescribe exercise for people with valvular heart disease or hypertension
thumbnail
Congress Presentation
Exercise and cardiovascular risk: friend or foe? - discussion
thumbnail
Congress Presentation
How should we prescribe exercise – and who should do it?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources